The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 03, 2016

Filed:

Oct. 25, 2012
Applicant:

The Regents of the University of Michigan, Ann Arbor, MI (US);

Inventors:

Max S. Wicha, Ann Arbor, MI (US);

Hasan Korkaya, Ann Arbor, MI (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); C12Q 1/68 (2006.01); C07K 16/28 (2006.01); C07K 16/32 (2006.01); C12N 15/113 (2010.01); A61K 31/337 (2006.01); A61K 31/685 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39558 (2013.01); A61K 31/337 (2013.01); A61K 31/685 (2013.01); A61K 39/3955 (2013.01); C07K 16/2866 (2013.01); C07K 16/32 (2013.01); C12N 15/113 (2013.01); C12Q 1/6886 (2013.01); A61K 2039/505 (2013.01); A61K 2039/507 (2013.01); C07K 2317/76 (2013.01); C12Q 2600/158 (2013.01);
Abstract

The present invention relates to compositions, methods, and kits for treating cancers with HER2 targeting agents and preventing resistance thereto. In particular embodiments, non-HER2-amplified cancers are treated with HER2 targeting agents, wherein the cancer stem cells in the cancer express HER2 and/or HER2 indicator marker. The present invention also relates to compositions, methods, and kits for detecting expression of HER2 and/or a HER2 indicator marker in non-HER2-amplified cancer samples from a subject, and identifying the subject as responsive to treatment with a HER2 targeting agent and/or treating the subject with a HER2 targeting agent.


Find Patent Forward Citations

Loading…